3M™ Kerramax Care™ Super-Absorbent Dressing
- 3M ID B5005265101
Details
Highlights
- Super-absorbent dressings for absorbing and retaining high levels of exudate¹ *
- Sequesters and retains bacteria and MMPs² ³ *away from the wound bed, preventing the transmission risk of infection
- Soft, conformable and foldable⁴
- Easy to apply⁴ using either side of the dressing
- Suitable for use under compression⁵ *
- Can be left in place for up to 7 days
3M™ Kerramax Care™ Dressings are a range of super-absorbent dressings that absorb and retain high amounts of wound exudate¹ *. The unique wicking layer evenly distributes fluid both horizontally and vertically throughout the dressing, utilizing the full absorption capacity. Exudate is locked away, including bacteria² * and MMPs³ *, creating an optimal environment for wound healing, helping to transform patient outcomes. Its high conformability allows the dressing to be folded to suit a variety of different wounds.
3M™ Kerramax Care™ dressings offer an advanced method of absorbing exudate from wounds utilising Exu-Safe™ Technology built into the dressing core. This super-absorbent core absorbs and retains moderate to high levels of fluid away from the wound bed – including bacteria2* and MMPs3* - protecting delicate wound tissue and surrounding skin whilst helping to reduce the risk of maceration, even under compression5*. The unique wicking layer draws up serous and viscous4 exudate, distributing it evenly throughout the dressing, utilising the full absorption capacity and helping to prevent bulking. Its heat-sealed border prevents exudate leakage. The dressings have a soft, non-woven material on both sides of the dressing, so either side can be placed on the wound whilst being comfortable for the patient.
1 Jackson, S. & Warde, D. Determination of free swell absorption and fluid retention, and absorption capacity under pressure of KERRAMAX CARE™. Crawford Healthcare Ltd. CHC R596. Knutsford, UK: 2017.
2Singh. G. & Thomason. H. Sequestration and retention of bacteria by superabsorbent dressings over time. KCI. CHC R1043 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
3 Singh. G. & Thomason. H. Sequestration of matrix metalloproteinases (MMPs) by superabsorbent wound dressings. KCI. CHC R1042 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
4 Hughes, M. A large-scale evaluation of managing moderate and highly exuding wounds in the community. Wounds UK. 2017;13(3):78-85.
5 Cotton, S. The management of a chronic leg ulcer using KERRAMAX CARE™ Super-Absorbent Dressing under compression. Poster presented at Wounds UK; November 2015; Harrogate, UK.
Specifications
Resources
Legal disclaimer
